Literature DB >> 26760588

Identifying predictors of low adherence in patients with inflammatory bowel disease.

Sofie Coenen1, Ellen Weyts, Vera Ballet, Maja Noman, Gert Van Assche, Séverine Vermeire, Jan Van Emelen, Marc Ferrante.   

Abstract

BACKGROUND AND AIM: Inflammatory bowel diseases (IBDs) are chronic gastrointestinal conditions requiring medical therapy to maintain clinical remission. Low adherence to therapy leads to poorer disease outcome. Therefore, we aimed to identify predictors of low adherence in the Belgian IBD population. PATIENTS AND METHODS: Between November 2013 and March 2014, 570 ambulatory patients (471 patients with IBD and 99 non-IBD controls) visiting a tertiary IBD-referral centre were requested to complete the Morisky 8-Item Medication Adherence Scale (MMAS-8) questionnaire as well as a survey of sociodemographic data (smoking, educational level, marital status and occupation). On the basis of the self-reported MMAS questionnaire, adherence was categorized as low (MMAS-8 score: >2), medium (MMAS-8 score: 1-2) or high (MMAS-8 score: 0).
RESULTS: The response rate in the IBD population was as high as 99%. Low adherence was reported less frequently in the IBD population than in the non-IBD controls (36 vs. 49%, P=0.021). In multivariate analysis, factors associated independently with low adherence in the IBD population were age younger than 40 [odds ratio: 1.589 (95% confidence interval: 1.057-2.389), P=0.026], higher educational level [1.961 (1.305-2.946), P=0.001], being single [1.641 (1.020-2.639), P=0.041] and the use of mesalamine [1.591 (1.018-2.487), P=0.041]. Self-employment was identified as a protective factor for low adherence [0.397 (0.167-0.946), P=0.041].
CONCLUSION: Approximately one-third of the IBD patients were low adherers. Predictors of low adherence were aged younger than 40 years, higher educational level, being single and mesalamine use, whereas being self-employed was a protective factor. On the basis of these data, personalized algorithms may be developed to improve patient education, empowerment and follow-up.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26760588     DOI: 10.1097/MEG.0000000000000570

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  11 in total

1.  College inflammatory bowel disease (C-IBD) day: a targeted approach to shared decision-making in college age students with IBD-a 2-year pilot project.

Authors:  Kofi Clarke; Mohammad Bilal; Heitham Abdul-Baki; Paul Lebovitz; Sandra El-Hachem
Journal:  Int J Colorectal Dis       Date:  2017-02-13       Impact factor: 2.571

2.  Assessing Oral Medication Adherence and Identifying Predictors of Low Adherence in Chinese Inflammatory Bowel Disease Patients.

Authors:  Wen Hu; Shurong Hu; Yimiao Zhu; Hanwen Chen; Yan Chen
Journal:  Patient Prefer Adherence       Date:  2020-07-02       Impact factor: 2.711

3.  Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease.

Authors:  Nisha B Shah; Jennifer Haydek; James Slaughter; Jonathan R Ashton; Autumn D Zuckerman; Rochelle Wong; Francesca Raffa; Ailish Garrett; Caroline Duley; Kim Annis; Julianne Wagnon; Lawrence Gaines; Robin Dalal; Elizabeth Scoville; Dawn B Beaulieu; David Schwartz; Sara N Horst
Journal:  Inflamm Bowel Dis       Date:  2020-01-06       Impact factor: 5.325

4.  Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis.

Authors:  Jin Lee; Sam Ryong Jee; Hyung Wook Kim; Dong Hoon Baek; Geun Am Song; Won Moon; Seun Ja Park; Hyun Jin Kim; Jong Hoon Lee; Jong Ha Park; Tae Oh Kim
Journal:  PLoS One       Date:  2019-03-22       Impact factor: 3.240

5.  Patient-Reported Nonadherence with Glaucoma Therapy.

Authors:  Christian Wolfram; Erik Stahlberg; Norbert Pfeiffer
Journal:  J Ocul Pharmacol Ther       Date:  2019-03-21       Impact factor: 2.671

6.  Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease.

Authors:  Sanjeevani K Tomar; Saurabh Kedia; Namrata Singh; Ashish D Upadhyay; Nagesh Kamat; Sawan Bopanna; Dawesh P Yadav; Sandeep Goyal; Saransh Jain; Govind Makharia; Vineet Ahuja
Journal:  JGH Open       Date:  2019-03-18

7.  Applying Machine Learning Models to Predict Medication Nonadherence in Crohn's Disease Maintenance Therapy.

Authors:  Lei Wang; Rong Fan; Chen Zhang; Liwen Hong; Tianyu Zhang; Ying Chen; Kai Liu; Zhengting Wang; Jie Zhong
Journal:  Patient Prefer Adherence       Date:  2020-06-03       Impact factor: 2.711

8.  Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle Container.

Authors:  Johannes P D Schultheiss; Sandra Altena; Max R Clevers; Dominique Baas; Bindia Jharap; Herma H Fidder
Journal:  Dig Dis Sci       Date:  2020-06-16       Impact factor: 3.199

9.  Young age and shorter duration of Crohn's disease are associated with non-adherence to taking medication.

Authors:  Hasan Yilmaz
Journal:  North Clin Istanb       Date:  2022-02-10

Review 10.  Preventive health measures in inflammatory bowel disease.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.